The WeTheNorth marketplace implemented a significant harm reduction initiative in late August 2025, integrating links to evidence-based harm reduction resources directly into substance listing pages. The integration was developed in collaboration with community harm reduction advocates and is designed to inform buyers about risks without being preachy or moralizing.
Each substance category now includes a collapsible information section containing: general risk information for the substance class, specific overdose recognition signs and first response guidance, drug interaction warnings (particularly for opioid combinations with other depressants), information about fentanyl contamination risk, and links to relevant professional harm reduction organizations.
The fentanyl test strip information is highlighted with particular urgency. The marketplace administration has consistently banned fentanyl and carfentanil listings since the platform's inception, but contamination from external supply chain issues remains a documented risk even on platforms with such bans. Independent drug checking data shows that fentanyl contamination has been detected in stimulant supplies, pressed pills, and other non-opioid substances — categories where buyers often do not expect opioid risk.
The initiative also includes naloxone location information specific to Canadian provinces, including pharmacy programs that provide naloxone kits free of charge without prescription. In several provinces, naloxone is available at no cost under provincial drug benefit programs.
Community response has been broadly positive. Harm reduction advocates outside the darknet space have noted that integrating practical safety information at the point of purchase — rather than relying on users to proactively seek it out — follows established evidence-based harm reduction practice.